Jamila Louahed

5.1k total citations
59 papers, 3.4k citations indexed

About

Jamila Louahed is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jamila Louahed has authored 59 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 26 papers in Oncology and 20 papers in Molecular Biology. Recurrent topics in Jamila Louahed's work include Immunotherapy and Immune Responses (24 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Immune Cell Function and Interaction (9 papers). Jamila Louahed is often cited by papers focused on Immunotherapy and Immune Responses (24 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Immune Cell Function and Interaction (9 papers). Jamila Louahed collaborates with scholars based in Belgium, United States and Italy. Jamila Louahed's co-authors include Jean‐Christophe Renauld, Laure Dumoutier, Vincent Brichard, Roy C. Levitt, Anne Vink, Jacques Van Snick, Nicholas C. Nicolaides, Thomas F. Gajewski, Frédéric Lehmann and Olivier Gruselle and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Jamila Louahed

58 papers receiving 3.4k citations

Peers

Countries citing papers authored by Jamila Louahed

Since Specialization

Citations

This map shows the geographic impact of Jamila Louahed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamila Louahed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamila Louahed more than expected).

Fields of papers citing papers by Jamila Louahed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamila Louahed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamila Louahed. The network helps show where Jamila Louahed may publish in the future.

Co-authorship network of co-authors of Jamila Louahed

This figure shows the co-authorship network connecting the top 25 collaborators of Jamila Louahed. A scholar is included among the top collaborators of Jamila Louahed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamila Louahed. Jamila Louahed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	IL‐9 exerts biological function on antigen‐experienced murine T cells and exacerbates colitis induced by adoptive transfer 2020 ·European Journal of Immunology ·Magali de Heusch, (unknown), (unknown), Jamila Louahed, Guy Warnier, Muriel M. Lemaire, Jean‐Christophe Renauld, Laure Dumoutier	6
2	A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non–Small Cell Lung Cancer 2019 ·Clinical Cancer Research ·Benjamin Dizier, Andrea Callegaro, Muriel Debois, Brigitte Dréno, Peter Hersey, Helen Gogas, John M. Kirkwood, Johan Vansteenkiste, Lecia V. Sequist, Djordje Atanackovic, Jelle J. Goeman, Hans C. van Houwelingen, Susana Alicia Salceda, (unknown), Patrick Therasse, C. Debruyne, Bart Spiessens, Vincent Brichard, Jamila Louahed, Fernando Ulloa‐Montoya	13
3	Expression of tumor-associated antigens in breast cancer subtypes 2019 ·The Breast ·Giuseppe Curigliano, Vincenzo Bagnardi, (unknown), Jamila Louahed, Vincent Brichard, Frédéric Lehmann, Antonio Marra, Dario Trapani, Carmen Criscitiello, Giuseppe Viale	26
4	Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: an open phase I/II study with a first assessment of a predictive gene signature 2017 ·ESMO Open ·Jean‐Jacques Grob, Laurent Mortier, Lionel D’Hondt, Florent Grange, Jean‐François Baurain, Brigitte Dréno, Célèste Lebbé, Caroline Robert, A. Dompmartin, Bart Neyns, Marc Gillet, Jamila Louahed, (unknown), Frédéric Lehmann	15
5	A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer 2016 ·Breast Cancer Research and Treatment ·Giuseppe Curigliano, Gilles Romieu, Mario Campone, Thierry Dorval, Lionel Duck, Jean‐Luc Canon, C. Roemer-Bécuwe, Mario Roselli, Silvia P. Neciosup, Wivine Burny, Andrea Callegaro, (unknown), Jamila Louahed, Vincent Brichard, Frédéric Lehmann	41
6	Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer 2015 ·Journal of Thoracic Oncology ·Jean-Louis Pujol, Johan Vansteenkiste, Tommaso Martino De Pas, Djordje Atanackovic, Martin Reck, Michiel Thomeer, Jean-Yves Douillard, Gianpiero Fasola, Vanessa Potter, Paul Taylor, Lionel Bosquée, Robert Scheubel, (unknown), Muriel Debois, (unknown), Jamila Louahed, Vincent Brichard, Frédéric Lehmann	51
7	MEK Inhibition, Alone or in Combination with BRAF Inhibition, Affects Multiple Functions of Isolated Normal Human Lymphocytes and Dendritic Cells 2014 ·Cancer Immunology Research ·Laura J. Vella, Anupama Pasam, Nektaria Dimopoulos, Miles C. Andrews, Ashley Knights, (unknown), Jamila Louahed, Weisan Chen, Katherine Woods, Jonathan Cebon	116
8	IL-9 Promotes IL-13-Dependent Paneth Cell Hyperplasia and Up-Regulation of Innate Immunity Mediators in Intestinal Mucosa 2009 ·The Journal of Immunology ·(unknown), Jamila Louahed, Muriel M. Lemaire, Caroline Sommereyns, Guy Warnier, Andrew N. J. McKenzie, Frank Brombacher, Jacques Van Snick, Jean‐Christophe Renauld	91
9	Clinical response to the MAGE-A3 immunotherapeutic in metastatic melanoma patients is associated with a specific gene profile present prior to treatment 2008 ·Annals of Oncology ·Jamila Louahed, Brigitte Dréno, Swann Gaulis, Thibault Helleputte, Pierre Dupont, Olivier Gruselle, Alan Spatz, Wim H.J. Kruit, Frédéric Lehmann, Vincent Brichard	8
10	GENE EXPRESSION SIGNATURE IS A POTENTIAL PREDICTIVE FACTOR FOR EFFICACY OF MAGE-A3 ANTIGEN-SPECIFIC CANCER IMMUNOTHERAPEUTIC (ASCI) AS ADJUVANT THERAPY IN RESECTED STAGE IB/II NON-SMALL CELL LUNG CANCER (NSCLC) 2008 ·Annals of Oncology ·J Jassem, Johan Vansteenkiste, M. Zieliński, Jubrail Dahabreh, A. Linder, (unknown), Benjamin Dizier, P. Therasse, Jamila Louahed, Vincent Brichard	2
11	IL-13 Mediates In Vivo IL-9 Activities on Lung Epithelial Cells but Not on Hematopoietic Cells 2007 ·The Journal of Immunology ·(unknown), Jamila Louahed, Ciriana Orabona, François Huaux, Guy Warnier, Andrew N. J. McKenzie, Dominique Lison, Roy C. Levitt, Jean‐Christophe Renauld	81
12	The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response 2007 ·Immunology ·(unknown), Jamila Louahed, (unknown), Benoı̂t Baras, Jean‐Christophe Renauld, Rita Vanbever	65
13	IL-9 Protects against Bleomycin-Induced Lung Injury 2005 ·American Journal Of Pathology ·Mohammed Arras, Jamila Louahed, Jean-François Heilier, Monique Delos, Frank Brombacher, Jean‐Christophe Renauld, Dominique Lison, François Huaux	23
14	IL-9-Induced Expansion of B-1b Cells Restores Numbers but Not Function of B-1 Lymphocytes in xid Mice 2004 ·The Journal of Immunology ·Laurent Knoops, Jamila Louahed, Jean‐Christophe Renauld	31
15	Local and Systemic Immune Responses to Intratracheal Instillation of Antigen and DNA Vaccines in Mice 2004 ·Pharmaceutical Research ·Catherine Lombry, (unknown), Mohammed Arras, Dominique Lison, Jamila Louahed, Jean‐Christophe Renauld, Véronique Préat, Rita Vanbever	26
16	Cloning and Characterization of IL-10-Related T Cell-Derived Inducible Factor (IL-TIF), a Novel Cytokine Structurally Related to IL-10 and Inducible by IL-9 2000 ·The Journal of Immunology ·Laure Dumoutier, Jamila Louahed, Jean‐Christophe Renauld	409
17	Interleukin-9 Upregulates Mucus Expression in the Airways 2000 ·American Journal of Respiratory Cell and Molecular Biology ·Jamila Louahed, Masao Toda, (unknown), Qutayba Hamid, Jean‐Christophe Renauld, Roy C. Levitt, Nicholas C. Nicolaides	211
18	Intraepithelial Infiltration by Mast Cells with Both Connective Tissue-Type and Mucosal-Type Characteristics in Gut, Trachea, and Kidneys of IL-9 Transgenic Mice 1998 ·The Journal of Immunology ·Catherine Godfraind, Jamila Louahed, Helen Faulkner, Anne Vink, Guy Warnier, Richard K. Grencis, Jean‐Christophe Renauld	110
19	Differential activity of dexamethasone on IL-2-, IL-4-, or IL-9-induced proliferation of murine factor-dependent T cell lines 1996 ·The Journal of Immunology ·Jamila Louahed, Jean‐Christophe Renauld, Jean‐Baptiste Demoulin, Gail Baughman, Suzanne Bourgeois, Kazuo Sugamura, J Van Snick	20
20	Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas 1995 ·Blood ·Jean‐Christophe Renauld, Anne Vink, Jamila Louahed, Jacques Van Snick	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact